DNA repair capacity: Inconsistency between effect of over-expression of five NER genes and the correlation to mRNA levels in primary lymphocytes

Mutation Research - DNA Repair

Volumn 461, Issue 3, 2000, Pages 197-210

  Vogel, Ulla ^a   Dybdahl, Marianne ^a   Frentz, Gerda ^b   Nexø, Bjørn ^a  

^a NATIONAL RESEARCH CENTRE FOR THE WORKING ENVIRONMENT   (Denmark)

^b Kommunehospitalet ^*  (Denmark)

Author keywords

HCR: Host cell reactivation; NER: Nucleotide excision repair; PBS: Phosphate buffered saline; PHA: Phytohemagglutinin

Indexed keywords

ARTICLE; CANCER RISK; CORRELATION FUNCTION; DNA REPAIR; EXCISION REPAIR; GENE EXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PSORIASIS;

BASE SEQUENCE; CELL LINE, TRANSFORMED; DNA PRIMERS; DNA REPAIR; HUMANS; LYMPHOCYTES; RNA, MESSENGER; TRANSFECTION;

EID: 0034626957     PISSN: 09218777     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0921-8777(00)00051-3     Document Type: Article

References (30)

1. Xeroderma pigmentosum: Cutaneous, ocular, and neurologic abnormalities in 830 cases
2. Reduced DNA repair capacity in lung cancer patients
3. DNA repair and susceptibility to basal cell carcinoma. A case-control study
4. Low DNA repair is a risk factor in skin carcinogenesis: A study of basal cell carcinoma in psoriasis patients
5. Reduced DNA repair capacity in head and neck cancer patients
6. Cisplatin and phorbol ester independently induce ERCC-1 protein in human ovarian carcinoma cells
7. Cisplatin induction of ERCC-1 mRNA expression in A2780/CP70 human ovarian cancer cells
8. Acquired cisplatin resistance in human ovarian cancer cells is associated with enhanced repair of cisplatin-DNA lesions and reduced drug accumulation
9. DNA excision repair
10. Malignant and nonmalignant brain tissues differ in their messenger RNA expression patterns for ERCC1 and ERCC2
11. Comparative analyses of relative ERCC3 and ERCC6 mRNA levels in gliomas and adjacent non-neoplastic brain
12. ERCC1 and ERCC2 expression in malignant tissues from ovarian cancer patients
13. Expression of excision repair genes in non-malignant bone marrow from cancer patients
14. Messenger RNA levels of XPAC and ERCC1 in ovarian cancer tissue correlate with response to platinum-based chemotherapy
15. Expression in normal human tissues of five nucleotide excision repair genes measured simultaneously by multiplex reverse transcription-polymerase chain reaction
16. Nucleotide excision repair in mammalian cells
17. Simultaneous amplification of four DNA repair genes and β-actin in human lymphocytes by multiplex reverse transcriptase-PCR
18. Northern Hybridisation: Rapid and simple electrophoretic conditions
19. Development and field-test validation of an assay for DNA repair in circulating human lymphocytes
20. One pyrimidine dimer inactivates expression of a transfected gene in xeroderma pigmentosum cells
21. Biosynthesis of peptide precursors and protease inhibitors using new constitutive and inducible eukaryotic expression vectors
22. Development of an new easy complementation assay for DNA repair deficient human syndromes using cloned repair genes
23. Polymorphism in the DNA repair gene XPD: Correlations with risk and age at onset of basal cell carcinoma
24. Seasonal variation of DNA damage and repair in patients with non-melanoma skin cancer and referents with and without psoriasis
25. Refined mapping of the three DNA repair genes ERCC1 ERCC2 and XRCC1 on chromosome 19
26. Sensitivity of group F xeroderma pigmentosum cells to UV and mitomycin C relative to levels of XPF and ERCC1 overexpression
27. Overexpression of the XPA repair gene increases resistance to ultraviolet radiation in human cells by selective repair of DNA damage
28. Damage recognition in nucleotide excision repair of DNA
29. Where transcription meets repair
30. p53 modulation of TFIIH-associated nucleotide excision repair activity